Tuesday, June 16, 2026

Johnson & Johnson invests over $1 billion in Jacksonville vision operations

Johnson & Johnson plans to invest more than $1 billion in Jacksonville, Florida, to expand its U.S. vision operations. The company said the project will add capacity in manufacturing, packaging and distribution for its ACUVUE contact lens business.

The investment includes advanced manufacturing and packaging technologies as well as a new distribution facility. According to Johnson & Johnson, the expansion is intended to improve supply chain resilience and support demand for ACUVUE contact lenses, which the company links to the needs of more than 40 million patients globally.

New facility targeted for full operation in 2028

Construction of the new facility is already underway, with full operational status targeted for 2028. The Jacksonville project forms part of Johnson & Johnson’s previously announced plan to invest $55 billion in U.S. manufacturing, research and development, and technology through early 2029.

The Jacksonville operations support about 3,500 employees. Johnson & Johnson also said its activities contribute approximately $6 billion annually to Florida’s economy.

Four decades of vision care activity in Florida

Johnson & Johnson has been active in Jacksonville since 1981. Its local footprint now covers more than 1.5 million square feet across manufacturing, research, distribution and operations. The company reports annual production of more than 1.7 billion ACUVUE contact lenses for U.S. patients.

For the healthcare and medtech industry, the announcement highlights the continuing focus of large manufacturers on domestic capacity and more resilient supply chains. In Johnson & Johnson’s case, the investment also reinforces Jacksonville’s role in its global vision care network.